In thе last 30 yеars and thе Amеricas havе witnеssеd a significant surgе in adults diagnosеd with diabеtеs and attributеd to ...

A U.S. senator said a GLP-1 drug changed his life — and now he’s calling for widespread access to anti-obesity medications.

This new Liraglutide injection is a generic equivalent for Victoza, which is a once-daily noninsulin medicine that lowers ...

Weight loss drugs like Ozempic gained popularity for managing obesity, diabetes, and related chronic conditions, a new study ...

Ozempic may be known for weight loss, but new studies reveal it could also protect brain health and lower your risk of dementia and Alzheimer’s.

Two new studies published in JAMA Neurology reveal that GLP-1 receptor agonists, like Ozempic and Trulicity, may ...

It’s possible that they may play a role as a preventative measure in the future,” said Dr. Catriona Reddin told The Post.

CHICAGO, IL, USA I April 03, 2025 I Meitheal Pharmaceuticals, Inc. (“Meitheal”), a fully integrated biopharmaceutical company based in Chicago focused on the ...

GLP-1 RAs can reduce liver fat, fibrosis progression, and resolve MASH, offering potential benefits for liver health. MASH significantly increases healthcare costs due to comorbidities like ...

Overweight and obesity are serious public health concerns that are closely tied to the development and progression of type 2 diabetes. These conditions are not just about appearance or weight — they ...

Type 3c diabetes, also known as pancreatogenic diabetes, is a form of diabetes that develops as a direct result of disease or damage to the pancreas. It is different from type 1 and type 2 diabetes ...

Novo will pay Hong Kong-based United Laboratories $200 million upfront for the drug, which combines three different ...